Literature DB >> 7726065

Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study.

M Lafortune1, J P Martinet, A Denys, H Patriquin, M Dauzat, M P Dufresne, L Colombato, G Pomier-Layrargues.   

Abstract

OBJECTIVE: The purposes of this study were to evaluate the effect of a well-functioning transjugular intrahepatic portosystemic shunt (TIPS) on the splanchnic and intrahepatic circulation, to determine if sonographic measurements can predict shunt dysfunction before clinical manifestations of portal hypertension occur, and to compare Doppler sonographic findings with portocaval gradient measurements before and after shunt revision. SUBJECTS AND METHODS: Forty-four patients with cirrhosis (n = 43) and myelofibrosis (n = 1) who underwent successful TIPS insertion were included in this prospective study. Indications for TIPS placement were: refractory ascites (24 patients), bleeding esophageal varices (17 patients), portal hypertensive gastropathy (two patients), and bleeding colonic varices (one patient). The portal vein and the inferior vena cava were catheterized; and the portocaval gradient was recorded before TIPS placement, at 2 and 12 months after TIPS placement, and when clinical or Doppler findings suggested shunt dysfunction. Doppler studies were done within 1 week before TIPS placement, within 2 days after TIPS placement, every 2-3 months thereafter, and before and after a TIPS revision. The Doppler studies included flow volume measurements in the portal vein and in the stent, as well as determination of the direction of flow in the segmental branches of the portal vein, in the splanchnic veins, and in portosystemic collaterals. Changes in Doppler findings and in catheter pressure measurements were compared using Spearman's rank correlation test. Significance was set at the .05 level.
RESULTS: A marked decrease (-51%) in portocaval gradient was observed after TIPS placement. At Doppler sonography, portal vein velocity and diameter were both higher after TIPS placement, resulting in a marked increase in portal venous flow (170%). Mean flow velocity in the shunt was 55.8 +/- 3.6 cm/sec, and flow volumes in the shunt and in the main portal vein were 1596 ml/min and 1731 ml/min, respectively (p = nonsignificant). Dysfunction of the stent occurred in 27% of the patients. Changes in stent blood flow volume were closely related to changes in the portocaval gradient (r = -0.67, p < .001). Reduction of blood flow volume in the stent or change of direction of flow in intrahepatic portal veins or in collateral veins signaled shunt dysfunction (84% sensitivity, 89% specificity).
CONCLUSION: Marked hemodynamic changes in the portal venous system occur soon after a TIPS procedure. Monitoring of shunt function with periodic Doppler sonography, including calculation of shunt blood flow, is useful in detecting shunt dysfunction before clinical signs occur.

Entities:  

Mesh:

Year:  1995        PMID: 7726065     DOI: 10.2214/ajr.164.4.7726065

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial.

Authors:  G Pomier-Layrargues; J P Villeneuve; M Deschênes; B Bui; P Perreault; D Fenyves; B Willems; D Marleau; M Bilodeau; M Lafortune; M P Dufresne
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

2.  The Feasibility of Using Volumetric Phase-Contrast MR Imaging (4D Flow) to Assess for Transjugular Intrahepatic Portosystemic Shunt Dysfunction.

Authors:  Joseph W Owen; Nael E Saad; Glenn Foster; Kathryn J Fowler
Journal:  J Vasc Interv Radiol       Date:  2018-11-03       Impact factor: 3.464

Review 3.  [Duplex ultrasound of the liver and portal vein system].

Authors:  H H Mohr; W Gödderz; K H Meyer zum Büschenfelde
Journal:  Med Klin (Munich)       Date:  1998-11-15

4.  Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.

Authors:  L A Colombato; L Spahr; J P Martinet; M P Dufresne; M Lafortune; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

5.  Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension.

Authors:  L Spahr; J P Villeneuve; M P Dufresne; D Tassé; B Bui; B Willems; D Fenyves; G Pomier-Layrargues
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

6.  Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.

Authors:  J P Martinet; D Fenyves; L Legault; L Roy; M P Dufresne; L Spahr; M Lafortune; G Pomier-Layrargues
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

Review 7.  Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.

Authors:  Sharad Sharma; Ahmet Gurakar; Nicolas Jabbour
Journal:  Dig Dis Sci       Date:  2007-11-09       Impact factor: 3.199

8.  The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.

Authors:  Gilles Pomier-Layrargues; Louis Bouchard; Michel Lafortune; Julien Bissonnette; Dave Guérette; Pierre Perreault
Journal:  Int J Hepatol       Date:  2012-07-19

9.  A Case of Isolated Duodenal Varices Secondary to Chronic Pancreatitis with Review of Literature.

Authors:  Venugopala Bommana; Prasun Shah; Michael Kometa; Rawan Narwal; Prashant Sharma
Journal:  Gastroenterology Res       Date:  2010-11-20

10.  Evaluation of Doppler-ultrasonography in the diagnosis of transjugular intrahepatic portosystemic shunt dysfunction: A prospective study.

Authors:  Charlotte Nicolas; Amélie Le Gouge; Louis d'Alteroche; Jean Ayoub; Monica Georgescu; Vincent Vidal; Denis Castaing; Jean-Pierre Cercueil; Patrick Chevallier; Jérôme Roumy; Hervé Trillaud; Louis Boyer; Vincent Le Pennec; Christophe Perret; Bruno Giraudeau; Jean-Marc Perarnau
Journal:  World J Hepatol       Date:  2017-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.